Immunotherapy for Mesothelioma Gets Boost with Another Orphan Drug Status …
Morphotek, Inc. was awarded Orphan Drug Status for amatuximab earlier this month, sending a ray of hope to early stage mesothelioma patients who are banking on immunotherapy in their battle to survive. Amatuximab (MORAb-009) is an investigational …
Full News here – Read more on Asbestos.com
Immunotherapy for Mesothelioma Gets Boost with Another Orphan Drug Status …
Posted on 25 November 2012.
Leave a Reply
-
58 Fans Like
-
1,232 Followers Follow
-
0 Subscribers Subscribe
- 13 insurers to compete on Calif. health exchange
- Insurers Competing For State's Health Care Exchange Proposed To Not Cover …
- New Asthma drug in testing phase
- New Asthma Drug Could Be Game Changer
- Jerome Bettis's Anti-Asthma Offensive
- lasik
-
CT scan (3/13) – Medical Informer Video
-
Cosmetic Surgery Documentary – Ethnic Nose Job – Plastic Surgeon Beverly Hills – Medical Informer Video
-
Aspirin Toner – Medical Informer Video
-
Animation about diabetes and the body. – Medical Informer Video
-
betatalk357: Personally, I'd rather be done with it in 10 minu...
-
xRipperx619: I hope and pray he will be alright and pulls throu...
-
dragondancer1814: Oh man, I know what you mean about that magnesium ...
-
wol5fe: 66 likes and 6 dislikes!!! 666!!! 0_0...
-
E. B.: Did you know that the device used to clean out ...
Stay up to date
- Subscribe to the RSS feed
- Subscribe to the feed via email
